OACC
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary ShareOACC
OACC
About: Oaktree Acquisition Corp III Life Sciences is a blank check company.
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
475% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 4
200% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 3 (+2) [Q1 2025]
95% more funds holding
Funds holding: 20 [Q4 2024] → 39 (+19) [Q1 2025]
71% more capital invested
Capital invested by funds: $89.8M [Q4 2024] → $153M (+$63.4M) [Q1 2025]
30.36% more ownership
Funds ownership: 45.45% [Q4 2024] → 75.81% (+30.36%) [Q1 2025]
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Research analyst outlook
We haven’t received any recent analyst ratings for OACC.
Financial journalist opinion
We haven’t received any recent news articles for OACC.
Charts implemented using Lightweight Charts™